NRx Pharmaceuticals, Inc. (NRXP) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 1.07M | 983K | 242K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 796K | 508K | 138K | 0 | 0 | 1K | 2K | 1K | 1K | 1K | 2K | 1K | 1K | 1K | 1K | 1K | 1K | 395 | 638 | 967 |
| COGS % of Revenue | 74.53% | 51.68% | 57.02% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 272K | 475K | 104K | 0 | 0 | -1K | -2K | -1K | -1K | -1K | -2K | -1K | -1K | -1K | -1K | -1K | -1K | -395 | -638 | -967 |
| Gross Margin % | 25.47% | 48.32% | 42.98% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | 47600% | 5300% | 100% | 100% | 0% | 0% | 0% | 0% | 0% | -100% | 0% | 0% | -153.16% | -56.74% | -3.41% | - | 55.62% | - | - |
| Operating Expenses | 5.02M | 5.07M | 4.22M | 3.73M | 3.85M | 3.63M | 3.02M | 7.05M | 6M | 4.41M | 5.81M | 7.94M | 9.43M | 9.89M | 9.14M | 9.6M | 15.7M | 52.97M | 20.1M | 17.12M |
| OpEx % of Revenue | 470.04% | 515.67% | 1744.63% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 3.71M | 4.51M | 2.79M | 2.74M | 2.94M | 2.6M | 2.41M | 4.25M | 4.25M | 1.87M | 2.49M | 4.06M | 5.78M | 5.43M | 5.01M | 6.64M | 10.22M | 46.56M | 13.82M | 12.46M |
| SG&A % of Revenue | 347.47% | 458.9% | 1154.13% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 1.31M | 558K | 1.43M | 987K | 804K | 1.04M | 611K | 2.8M | 1.75M | 2.53M | 3.31M | 3.87M | 3.65M | 4.46M | 4.13M | 2.96M | 5.48M | 6.41M | 6.28M | 4.66M |
| R&D % of Revenue | 122.57% | 56.77% | 590.5% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 100K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.75M | -4.59M | -4.12M | -3.73M | -3.85M | -3.63M | -3.02M | -7.05M | -6M | -4.41M | -5.81M | -7.94M | -9.44M | -9.89M | -9.14M | -9.6M | -15.71M | -52.97M | -20.1M | -17.12M |
| Operating Margin % | -444.57% | -467.34% | -1701.65% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -23.42% | -26.42% | -36.27% | 47.09% | 35.86% | 17.52% | 47.97% | 11.19% | 36.43% | 55.44% | 36.46% | 17.31% | 39.92% | 81.33% | 54.52% | 43.91% | -213.47% | -388.72% | -148.59% | -793.31% |
| EBITDA | -4.58M | -4.49M | -4.08M | -17.58M | -5.51M | -3.63M | -3.02M | -7.05M | -6M | -4.41M | -5.81M | -7.94M | -9.43M | -9.89M | -9.14M | -9.6M | -15.7M | -52.97M | -20.1M | -17.12M |
| EBITDA Margin % | -429.12% | -457.17% | -1684.71% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 16.85% | -23.7% | -35% | -149.41% | 8.09% | 17.53% | 47.98% | 11.19% | 36.43% | 55.45% | 36.48% | 17.31% | 39.93% | 81.34% | 54.52% | 43.92% | 38.38% | -388.76% | -290.32% | -16429.11% |
| D&A (Non-Cash Add-back) | 165K | 100K | 41K | 0 | 0 | 1K | 2K | 1K | 1K | 1K | 2K | 1K | 1K | 1K | 1K | 1K | 1K | 395 | 638 | 967 |
| EBIT | -4.75M | -4.59M | -4.12M | -17.58M | -5.51M | -9.08M | -1.62M | -7.05M | -6.3M | -4.25M | -6.02M | -8.72M | -11.04M | -10.24M | -9.08M | -6.98M | -13.45M | -30.79M | -37.04M | -112.5K |
| Net Interest Income | -228K | -667K | 2K | 2K | 4K | 4K | 6K | -842K | -203K | -6K | 79K | 145K | 156K | 130K | 95K | 23K | -3K | -2.34K | -5K | -5.11K |
| Interest Income | 5K | 4K | 2K | 2K | 4K | 4K | 6K | 7K | 27K | 74K | 119K | 145K | 156K | 130K | 95K | 23K | 0 | 0 | 368 | 0 |
| Interest Expense | 233K | 671K | 0 | 0 | 0 | 0 | 0 | 849K | 230K | 80K | 40K | 0 | 0 | 0 | 0 | 0 | 3K | 2.34K | 5.37K | 5.11K |
| Other Income/Expense | 3.32M | 4.95M | -1.77M | -13.85M | -1.67M | -5.44M | 1.4M | -847K | -530K | 74K | -254K | -779K | -1.6M | -353K | 58K | 2.62M | 2.26M | 22.18M | -16.95M | 17M |
| Pretax Income | -1.43M | 360K | -5.89M | -17.58M | -5.51M | -9.08M | -1.62M | -7.9M | -6.53M | -4.33M | -6.06M | -8.72M | -11.04M | -10.24M | -9.08M | -6.98M | -13.45M | -30.79M | -37.05M | -117.61K |
| Pretax Margin % | -133.9% | 36.62% | -2433.88% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -1.43M | 360K | -5.89M | -17.58M | -5.51M | -9.08M | -1.62M | -7.9M | -6.53M | -4.33M | -6.06M | -8.72M | -11.04M | -10.24M | -9.08M | -6.98M | -13.45M | -30.79M | -37.05M | -117.61K |
| Net Margin % | -133.9% | 36.62% | -2433.88% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 74.06% | 103.97% | -262.91% | -122.63% | 15.56% | -109.56% | 73.23% | 9.41% | 40.86% | 57.7% | 33.26% | -24.85% | 17.91% | 66.74% | 75.48% | -5836.42% | 47.24% | 31.76% | -617.77% | -214.98% |
| Net Income (Continuing) | -1.43M | 360K | -5.89M | -17.58M | -5.51M | -9.08M | -1.62M | -7.9M | -6.53M | -4.33M | -6.06M | -8.72M | -11.04M | -10.24M | -9.08M | -6.98M | -13.45M | -30.79M | -37.05M | -117.61K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.04 | 0.01 | -0.27 | -0.98 | -0.34 | -0.86 | -0.15 | -0.75 | -0.74 | -0.05 | -0.74 | -0.12 | -0.19 | -0.09 | -0.14 | -0.07 | -2.10 | -0.60 | -0.38 | -64.30 |
| EPS Growth % | 87% | 101.31% | -80% | -30.67% | 54.05% | -1566.67% | 79.73% | -525% | -289.47% | 40.07% | -428.57% | -80.72% | 90.95% | 85.65% | 63.16% | 99.9% | 70.42% | 96.41% | -171.43% | - |
| EPS (Basic) | -0.04 | 0.01 | -0.27 | -0.98 | -0.34 | -0.86 | -0.15 | -0.75 | -0.74 | -0.05 | -0.74 | -0.12 | -0.19 | -0.09 | -0.14 | -0.07 | -0.18 | -0.60 | -0.38 | -61.30 |
| Diluted Shares Outstanding | 32.33M | 31.73M | 22.23M | 17.93M | 16.41M | 10.52M | 10.97M | 10.52M | 8.85M | 83.92M | 8.2M | 73.22M | 67.45M | 66.45M | 66.45M | 65.73M | 63.67M | 51.74M | 54.81M | 42.49M |
| Basic Shares Outstanding | 32.33M | 31.73M | 22.23M | 17.93M | 16.41M | 10.52M | 10.97M | 10.52M | 8.85M | 83.92M | 8.2M | 73.22M | 67.45M | 66.45M | 64.88M | 65.73M | 63.67M | 51.74M | 54.81M | 41.73M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |